RA0030

antibody from Oursmab

Targeting: AXL ARK, JTK11, Tyro7, UFO

Western blot (Data presented on provider website)

ELISA (Data presented on provider website)

Immunocytochemistry (Recommended by provider)

Flow cytometry (Recommended by provider)

Functional assay (Recommended by provider)

Antibody Data

Product number

RA0030

Provider

Oursmab

Product name

Enapotamab (Biosimilar Reference Antibody) (AXL)

Antibody type

Monoclonal

Description

Enapotamab (development code HuMax-AXL-ADC) is an investigational antibody-drug conjugate (ADC) developed for the treatment of solid tumors. It is engineered by linking a potent cytotoxic drug (a tubulin inhibitor) to a fully human monoclonal antibody via a cleavable linker. Enapotamab functions as a targeted chemotherapy agent, where the antibody component specifically delivers the cytotoxic payload to cancer cells expressing its target receptor. Upon binding, the ADC is internalized into the target cell, where the linker is cleaved, releasing the drug to disrupt microtubule formation, ultimately leading to tumor cell death.

Reactivity

Human

Isotype

IgG

Vial size

100 ¦Ìg,1 mg,5 mg,10 mg,25 mg,50 mg,100 mg

Concentration

Bottled at the concentration indicated on the vial.

Storage

Store at -20¡ãC or -80¡ãC. Avoid repeated freeze.